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Abstract
Background: Human papillomavirus (HPV) has been observed repeatedly in esophageal squamous cell carcinoma (ESCC)
tissues. However, the causal relationship between HPV infection and the onset of ESCC remains unknown. A large cohort
study focusing on this topic is being carried out in rural Anyang, China.
Methodology/Principal Findings: The Anyang Esophageal Cancer Cohort Study (AECCS) is a population-based prospective
endoscopic cohort study designed to investigate the association of HPV infection and ESCC. This paper provides
information regarding the design and implementation of this study. In particular we describe the recruitment strategies and
quality control procedures which have been put into place, and the custom designed computer-aided survey system (CASS)
used for this project. This system integrates barcode technology and unique identification numbers, and has been
developed to facilitate real-time data management throughout the workflow using a wireless local area network. A total of
8,112 (75.3%) of invited subjects participated in the baseline endoscopic examination; of those invited two years later to
take part in the first cycle of follow-up, 91.9% have complied.
Conclusions/Significance: The AECCS study has high potential for evaluating the causal relationship between HPV infection
and the occurrence of ESCC. The experience in setting up the AECCS may be beneficial for others planning to initiate similar
epidemiological studies in developing countries.
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Introduction
Esophageal cancer is a common and often fatal malignancy,
and it shows a striking geographic variation in incidence [1,2].
One of the highest incidence regions for this neoplasm is in the
Anyang region of Northern China, and the major etiologic factors
for development of esophageal cancer in this region remain to be
determined [3,4,5,6,7].
The association between human papillomavirus (HPV) infection
and esophageal squamous cell carcinoma (ESCC) has been under
investigation since the early 1980s, and results have been
inconsistent [8,9,10,11,12,13,14]. We have documented the
presence of HPV DNA in many esophageal cancer specimens
collected in Anyang [15]. Moreover, a case-control study in this
population observed that the presence of HPV DNA in cancer
specimens and the presence of HPV-16 E7 antibody in sera were
associated with an increased risk of ESCC (Unpublished
manuscript). In order to further investigate the causal relationship
between HPV infection and the incidence of ESCC, the Anyang
Esophageal Cancer Cohort Study (AECCS) was launched in 2006.
The AECCS seeks to: 1) explore the natural history of HPV
infection in esophageal epithelium; 2) investigate modes of
transmission of HPV infection to the esophagus; and 3) evaluate
the association between HPV infection and the occurrence of
ESCC.
The design and implementation of this prospective cohort study
has posed numerous challenges. First, a large sample size and long
duration of follow-up are required due to the low incidence of
ESCC [16]. Second, in order to evaluate the possibility of spread
of HPV infection from one part of the body to another,
examination of multiple sites on each individual for HPV in
addition to the esophagus is essential, and this complicates study
procedures and data management. Third, the study is being
carried out in a region of limited resources where some modern
technologies (such as stable Internet connections) are not available
[17,18]. The relatively low educational level of participants has
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31602also posed a challenge [19]. In this article we seek to describe the
design and implementation of the AECCS.
Methods
Study design
The primary exposure to be investigated in the AECCS is
esophageal HPV infection, determined by evaluating the HPV
DNA status of endoscopic biopsy specimens using polymerase
chain reaction (PCR) followed by sequencing and the HPV
antibody status in sera using enzyme-linked immunosorbent assay
(ELISA) [15]. The primary endpoint is the presence of ESCC/
precancerous lesions (identified by endoscopic examination and
subsequent pathological diagnosis of biopsy tissues [20]) or
clinically diagnosed ESCC. The AECCS is being conducted in
Anyang, the northernmost area of Henan Province, China.
Anyang consists of five rural counties, including Anyang, Hua,
Lin, Neihuang, and Tangyin, which have a total of 4.37 million
people. The mortality rate for ESCC in this area is about 50 per
100,000 person-years [21]. Anyang is an agricultural region of
low-income with a per capita gross domestic product (GDP) of
$1,760 (USD). Like other rural areas of China, more than 94% of
rural populations in Anyang are covered by New Rural
Cooperative Medical Scheme (NRCMS, a government-run
voluntary insurance) and the inpatient reimbursement proportion
is about 50% on average [22]. To represent the spectrum of
villages in Anyang according to location, population size,
administrative capabilities, etc., five villages (Hengcun, Malan,
Xiaopu, Xitaoyuan and Zhuzhao) from Hua County, two
(Chengbei and Shencun) from Lin County (also called Linxian,
or Linzhou), one (Shangzhuang) from Anyang County and one
(Tunzhuang) from Tangyin County were selected for inclusion in
the study. Eligibility criteria for participation were as follows: 1)
permanent residency in one of the selected villages; 2) age between
25 and 65 years; 3) no self-reported history of cancer,
cardiovascular disease, mental disorder, or other contraindications
for endoscopy; 4) no self-reported history of infection with hepatitis
B virus (HBV), hepatitis C virus (HCV), or human immunode-
ficiency virus (HIV) (and no evidence of these infections based on
serum screening); and 5) willingness to participate in AECCS and
complete all parts of the examination. Over 8,000 residents were
eligible to be recruited into the cohort, and follow-up is planned
for a 10-year period at 2-year intervals. All medical procedures
carried out in the AECCS are free of charge, no financial or other
incentive is given to participants, except a light meal after
completion of examinations. The ESCC patients identified in this
cohort are given RMB 1,000 (1,000 Renminbi<$150 USD) to
reduce the financial burden of cancer treatment. This study was
conducted according to the principles expressed in the Declaration
of Helsinki. Every attempt to protect participants’ privacy and
confidentiality has been made, including labeling specimens with a
unique number without exposing any personal information and
publishing anonymously. Research protocols and related materials
were submitted to and approved by an independent ethics
committee, the Institutional Review Board of the School of
Oncology, Peking University, China (Approval number: 2006020).
All participants provided written informed consent.
Organization of fieldwork
The AECCS fieldwork infrastructure includes three tiers of
responsibility (Figure 1). The first tier is the steering committee
which consists of the Principal Investigators and scientific experts
who are responsible for study design and decisions regarding study
implementation. The second tier is the fieldwork executive team,
which consists mainly of local dialect-speaking staff who have
medical backgrounds. This tier, led by the field coordinator,
carries out the routine survey procedures in the AECCS study
center and oversees specific elements of the fieldwork through
contact with village committees. The study center resides in Hua
County Hospital, the largest general hospital in the study region,
and this hospital is located an average of 25 miles from the villages
selected for study. A motor vehicle is employed for transportation
of participants back and forth from the study center. The study
center is fully supported by Hua County Hospital and is allowed
access to its clinical laboratory, emergency room and supply
division. Nine village committees represent the third tier of the
infrastructure and play a critical role in participant recruitment.
Each village committee consists of the administrative head of the
village together with subordinate group leaders of the neighbor-
hood. The size of these subordinate groups ranges from 50 to 200
residents, and group leaders are familiar with resident information
and are able to contact individuals as need be in the target
population. Village committees are also responsible for monitoring
the occurrence of clinically diagnosed cancers, whereabouts, and
vital status of cohort members.
Participant recruitment
The original recruitment process was led by the field
coordinator and carried out by village committees. The recruit-
ment event was first announced by village leaders and bulletins
were displayed in all villages. This was followed by house-to-house
recruitment carried out by group leaders based on a list of
potential participants obtained from village security offices. During
home visits, group leaders described the study in a more detailed
manner and answered questions. Residents without any self-
reported history of conditions which would render them ineligible
were invited to attend a hospital appointment in a non-coercive
way. If villagers were not at home at the first visit, 2 additional
attempts were made. Permanent residents who were temporarily
away (e.g. working elsewhere) were recruited by telephone and
flexible schedules were arranged. Village committees met with the
field coordinator on a bi-weekly basis to provide information on
the progress of recruitment, to discuss specific problems, and to
schedule visits.
Baseline investigation
Registration and blood screening. Demographic
information for potential study participants including name,
gender and date of birth was obtained from village security
offices and preloaded into the study database. When participants
presented to the study center, a personal identification card issued
by the Chinese government was required. After confirmation of
identity and contact information, a digital photograph was taken,
and a unique study identification (ID) number and barcode were
automatically generated by the database. Investigators told the
potential participants about the discomforts and risks of all
involved examinations, and ensured them informed that
participation is voluntary and non participation or withdrawal
will not result in any penalty or loss of benefits to which they are
otherwise entitled. An informed consent statement was then signed
by each invitee who decided to take part in the study. Each
participant gave two blood samples. One sample was used for
screening for HBV, HCV, and HIV infection, and individuals
with evidence of any of these infections were excluded from the
cohort. The other blood sample (5 ml) was centrifuged, and serum
and blood cells were temporarily stored at 220uC and later
transferred to Beijing Cancer Hospital and Institute, and frozen at
280uC.
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trained interviewer. The electronic questionnaire, which is linked
with the study database, includes more than 50 items regarding
demographic characteristics, medical history, family history of
cancer, personal behavior (e.g. smoking and drinking), dietary
habits, hygienic habits, sexual behavior, and for women,
menstrual/reproductive history.
Collection of exfoliated cells. Exfoliated cells of oral cavity,
palmar skin, and genitalia were collected (Collection of palmar
exfoliated cells and male genital exfoliated cells was limited to 6
villages during baseline evaluation). Oral exfoliated cells were
collected from inner cheeks, inner lower and upper lip, palate, and
surfaceof the tongue by swabbing five times after rinsing the mouth.
Palmar exfoliated cells were collected from the entire surface of the
palm by scraping with steady pressure. Exfoliated cells were also
obtained from the genitalia. For women, a gynecologic examination
was performed before cell collection, and any abnormalities were
recorded. Cervical secretions were cleared, and then the exfoliated
cells were collected by insertion of swab into the cervix and rotation
of 360u five times. Cells were immediately smeared onto a slide and
fixed for cytological examination, and the swab was then processed
for cells for further analysis. For men, the upper 1/3 of the scrotum
and entire surface of the penile shaft, coronal sulcus and glans penis
were swabbed five times.
Exfoliated cells collected on swabs were rinsed into 0.9% saline
solution and centrifuged. Cell pellets were first frozen at 220uC
and later at 280uC.
Endoscopic biopsy. The esophagus and stomach were
inspected via endoscopy and all abnormalities were biopsied. If
no lesions were found, a biopsy was taken at the mid-esophagus for
pathologic examination. In addition, biopsies from the 6 and 12
o’clock positions 25 cm distal to the incisors were taken for HPV
testing. Using the endoscopic imaging system, an electronic
endoscopy report was completed and stored in the database. A
copy of the report was given to the participant.
Follow-up
The participant roster is updated every 2 years, with addition of
new qualified residents (e.g. new 25-year-old residents) and
removal of participants who have reached study end-points in
the previous cross-section. All subjects on the roster are contacted
for follow-up examinations, which are identical to those performed
for the baseline study except that the follow-up questionnaire
mainly focuses on changes in exposures of ESCC or HPV relevant
factors in the preceding 2-year interval. Information on incident
clinically diagnosed cancers, deaths, and migration occurred
during the interval since the previous cross-section is also obtained
through follow-up home visits. Death certificates are then
requested from local medical service units to verify the date and
cause of death. For cohort members who are newly diagnosed with
ESCC, relevant medical records, histology slides, and tumor tissue
blocks are collected from the diagnostic hospital for confirmation
of cancer diagnosis and future studies.
Computer-aided survey system
In order to facilitate data collection, data management, and
quality control, particular effort was taken in developing a custom
designed computer-aided survey system (CASS). To support the
synchronization and sharing of data across multiple examination
rooms without the benefit of Internet access, information
technologies including use of barcodes, ID numbers, and wireless
local area network (WLAN) were integrated into CASS (Figure 2).
Data can thus be entered and retrieved in the Structured Query
Language (SQL) Server 2005 database via logging into client
computers. Thus, the CASS server/client mode allows real-time
data entry and management, and permits all procedures to run
simultaneously.
At the same time, this information system allows for dynamic
monitoring of study progress. For example, up-to-date survey
status information can be accessed by the study staff to identify a
participant whose data are incomplete so that information can be
amended even before the individual leaves the study center. This
system also makes it possible to rapidly produce statistical reports
to order in order to obtain an overview of the study while it is in
progress. On the other hand, to ensure the completeness, accuracy
and consistency of data, check functions and skip patterns were
programmed into the database wherever possible. For example,
Figure 1. Three-level infrastructure of the AECCS. This figure illustrates how three tiers of responsibility are integrated in the fieldwork
infrastructure for optimal interaction with the target population in the Anyang Esophageal Cancer Cohort Study, Anyang, China, 2006-present. There
are a total of nine village committees in the third tier of the infrastructure.
doi:10.1371/journal.pone.0031602.g001
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31602Figure 2. Computer-aided survey system (CASS) with client/server mode using a WLAN. The hosting system for the database resides on
the server. The staff in each examination room can synchronously enter data in the database by logging into client application software installed on
client computers using a wireless local area network (WLAN). After registration, blood is drawn. Eligible participants with no communicable blood
diseases then continue on and participate in an interview and examination of the oral cavity, palmar skin, cervix/penis and esophagus.
doi:10.1371/journal.pone.0031602.g002
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may be submitted to the database.
Quality control
To minimize variation in implementation of procedures by
various staff members over time, standardized operation protocols
(SOPs) have been developed, and personnel are trained and
certified according to these SOPs. In particular, since HPV cross-
contamination can adversely influence the accuracy of results,
SOPs detailing anti-contamination measures have been estab-
lished. In addition, procedures evaluating the effectiveness of anti-
contamination have been included. Mock samples, such as mouse
liver free of HPV, are processed together with biopsies and cells,
and swabs of the working environment are routinely collected
[23]. Periodically, all these mouse liver and swab samples are
tested for human beta-globin and HPV DNA negativity. Random
samples of tape-recorded interviews are also routinely reviewed
and evaluated for protocol adherence.
Results
In the baseline phase of the AECCS (2006 to 2009), of 11,554
permanent residents from selected villages of ages ranging from 25
to 65, 269 were excluded because of death and self-reported
ineligibility (Figure 3). Of the remaining 11,285 candidate
residents, 9,561 (84.7%) had blood drawn. Of these individuals,
513 (5.4%) were excluded from the cohort, including 414 who
were positive for HBV, 96 for HCV and 3 for HIV. Thus, 10,772
(11,285 minus 513) residents were included as eligible. Of these
potential participants, 8,638 (80.2%) completed a baseline
interview and 8,112 participated in an endoscopic examination,
yielding a final response proportion of 75.3% (8,112/10,772)
(Table 1). The response proportions for examination of oral cavity,
palmar skin, cervix and penis were 75.3%, 82.6%, 77.2%, and
84.6%.
The mean age of participants who underwent baseline
endoscopy was 44.3 years (Standard deviation 10.5 years) and
the male to female sex ratio was 1.00 to 1.11 (Table 2). More than
40% of these participants had not attended high school or higher
levels of education and about 60% were currently farming for their
livelihood. Approximately 7.6% reported having a family history
of esophageal cancer. In the baseline study, 20 ESCCs, 2
esophageal adenocarcinomas, 4 cardiac adenocarcinomas, 1
gastric adenocarcinomas, 1 duodenal adenocarcinoma and 14
cervical carcinomas were identified.
The first follow-up for the AECCS began in 2009, and to date
follow-up has been completed for 3 villages. Of the 2,899 eligible
residents from these 3 villages, 2,664 (91.9%) have undergone a
follow-up endoscopic examination.
Discussion
This paper describes the design and implementation of the
AECCS, which is one of the largest prospective esophagogas-
troduodenoscopic cohort studies undertaken to date. In view of the
fact the cohort is large, the frequency of study follow up is
relatively high, and the length of follow-up is long, this study has
high potential for evaluating the relationship between esophageal
HPV infection and the occurrence of ESCC. To maximize the
validity of this study, carefully-designed recruitment strategies and
a tailored computer-aided survey system have been employed.
Participation and retention have been high, as reflected by the fact
that 8,112 (75.3%) participants underwent baseline endoscopic
examination and 91.9% of invited subjects have, to date,
participated in the first cycle of follow-up. In view of the initial
success of this study, the methodology we have employed for
implementing AECCS may provide benefit for others who plan to
launch similar large-scale epidemiological studies in low-resource
regions.
Based on data from our case-control study mentioned above,
the proportion of individuals positive for HPV DNA in the normal
esophagus in this region is expected to be about 5%. Due to the
repeated and transient nature of infection characteristic of HPV,
we estimate that 15% of subjects will have been characterized as
HPV-exposed after a 10-year follow-up. In addition, since ESCC
has a very poor prognosis, the incidence rate is approximately
equal to the mortality rate which is about 50 per 100,000 person-
years [21,24]. Moreover, we estimate that there will be a 10% loss
of participants at every cross-sectional examination, so that some
malignant lesions that do not progress to clinically-evident cancer
will be missed. Therefore, using a two-sided log-rank test on the
significance level of 0.05 and an enrollment of 8,112 subjects in the
baseline investigation, the AECCS would have 80% power to
detect risk ratios greater than 3.0 (PASS 2008 software) (Figure
S1). The odds ratio of HPV exposure obtained in our case-control
study was approximately 6.0. Thus, the current sample size of this
cohort can be considered adequate for evaluating the relationship
of esophageal HPV infection and the onset of ESCC (Table S1).
In the AECCS, population-based endoscopic examination is
carried out biennially in participants across a wide age range (25–
65 years). The inclusion of younger participants is anticipated to
yield valuable data regarding HPV infection and onset of
esophageal lesions. Ideally, we would have included even younger
people in order to capture the time of onset of sexual activity for
measurement of HPV infection [25]. However, requesting large
number of individuals under age 25 to undergo endoscopy is not
feasible. Due to the transient nature of HPV infection, follow-up
with repeated examination to ascertain HPV infection status of an
individual will reduce misclassification of exposure [26,27,28]. At
the same time, as the study size is large and the age range is wide,
related studies can be incorporated in a cost-effective way.
Examinations of the oral cavity, palmar skin, and genitals are
carried out simultaneously, which enables investigation of
outcomes in other organ systems such as the female genital tract
and may allow us to study modes of transmission of HPV infection
to the esophagus.
As a rule of thumb, a high response proportion is an indicator of
good survey practice [29]. Compared to some studies with lower
participant burden, AECCS requires relatively substantial time
commitments and involves invasive procedures [30]. Therefore,
more efforts are demanded to achieve a satisfied participation
proportion. The attained high level of response to AECCS
recruitment and follow-up can be attributed to several factors.
First, there has been full support from local health providers and
the local government. For example, establishment of the study
center in the local hospital has provided participants a safe and
comfortable environment for required examinations which has
improved recruitment. Second, well organized fieldwork has been
vital to the success of recruitment. The fieldwork coordinator has
excellent skills in working with local residents and influential
members of the village committees, and has served as a strong
bridge between investigators and the target population. Thus,
culturally appropriate, non-coercive recruitment strategies have
been developed to motivate participation and to avoid misunder-
standing. In addition, regular meetings to discuss progress and
challenges have helped sustain and promote recruitment. Last but
not least, performance quality and the friendly attitude of study
personnel have also been crucial in this low medical resource
The Anyang Esophageal Cancer Cohort Study
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continuously available to explain examination results and to
answer other medical questions from participants. We believe that
participants thus have had generally positive experiences and
frequently shared their trust in our work with other invitees.
Altogether, while our experience should not be regarded as an
exact recruitment recipe, it is clear that crafting and using study-
specific strategies to reconcile the unique cultural barriers and
concerns will be paramount to success in recruitment and
retention [31].
The successful use of CASS in this cohort also deserves mention.
First, use of CASS has allowed high-quality data to be obtained,
stored and retrieved in an efficient, inexpensive manner. The
incorporation of ID numbers, barcodes and photographs through-
out the workflow has ensured accurate subject identification,
which may be a serious challenge in resource-limited settings, and
has significantly reduced potential manual input mistakes [19,32].
Up-to-date retrieval of individual examination status has mini-
mized accidental missing responses to examination items, and the
built-in check functions have almost completely eliminated
inaccuracies, inconsistencies, and incorrect data [33]. Second,
CASS features real-time statistical evaluation of data enabling staff
to efficiently and accurately produce various kinds of progress
reports at any given time. Thus, labor intensive work, such us
manually merging multiple databases to determine the progress of
ongoing investigation, has been avoided. Use of this system has
also ensured data security. Limitation of user’s authority, use of
WLAN to avoid public exposure of data, and routine database
Figure 3. Flow diagram of participants. This figure illustrates the flow diagram of participants through enrollment, serum screening and
endoscopic examination in the baseline investigation of Anyang Esophageal Cancer Cohort Study, Anyang, China, 2006–2009.
doi:10.1371/journal.pone.0031602.g003
Table 1. Number of participants and response proportions in the baseline investigation, Anyang Esophageal Cancer Cohort Study
(2006–2009).
Examination items Eligible subjects Participants Response proportions
No. No. Percent
Interview 10,772 8,638 80.2
Endoscopic examination 10,772 8,112 75.3
Examination of oral cavity 10,772 8,109 75.3
Examination of palmar skin{ 7,210 5,958 82.6
Examination of cervix{ 5,401 4,171 77.2
Examination of penis{ 3,571 3,021 84.6
{Examination of palmar skin and penis was limited to 6 villages (Hengcun, Malan, Tunzhuang, Xiaopu, Xitaoyuan, and Zhuzhao) in the baseline investigation.
{Fifty women with previous hysterectomies did not have a cervical examination.
doi:10.1371/journal.pone.0031602.t001
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malfunction of CASS have all served to ensure data safety.
There are concerns which must be addressed regarding
sustaining this cohort for ongoing study. Long-term retention of
subjects will be one of the most challenging issues we may confront
in the future. In the wake of economic growth in China, it is
anticipated that there will be an increase in participants moving
back and forth from their original residential place for reasons of
employment. This will greatly increase the difficulty of retention of
this cohort. It is clear that additional retention strategies and
funding will be needed to maintain long-term follow-up.
Supporting Information
Figure S1 Setup of parameters to calculate sample size
for AECCS (PASS 2008 software). The follow-up of Anyang
Esophageal Cancer Cohort Study (AECCS) is planned for a 10-
year period at 2-year intervals. We estimate that there will be a
10% loss of participants at every cross-sectional examination
(every 2 years), so proportion lost during 1 year is about 5.13%
(See the following). The incidence rate of ESCC in unexposed
group is 38.45 per 100,000 person-years (See the following). Let
Plost1 denote the proportion lost during 1 year and let Plost2 denote the
proportion lost during 2 years (which is 10%), then (12Plost1)‘2=12Plost2
assuming that lost to follow-up is constant over time. Thus,
Plost1=12(1210%)‘0.5=0.0513. Let P0 denote the incidence rate of
ESCC in unexposed group, let P denote the incidence rate of the target
population (which is 50 per 100,000 person-years), let RR denote risk ratio
(which is 3.003) and let R denote sample size ratio of unexposed group (N2)t o
exposed group (N1) (which is equal to 85%/15%=5.67), then
P=(R 6N16P0+RR6N16P0)/(R6N1+N1). Thus P0=P 6(1+R)/
(R+RR)=0.00056(1+5.67)/(5.67+3.003)=0.0003845.
(TIF)
Table S1 Statistical power calculation for Anyang
Esophageal Cancer Cohort Study under different sce-
narios combining various values of sample size, pro-
portion of exposed group and risk ratio.
(DOC)
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